A preliminary investigation of worry, cortical amyloid burden, and stressor-evoked brain and cardiovascular reactivity in older adults
Thomas E. Kraynak(University of Pittsburgh), Carmen Andreescu(University of Pittsburgh), Tharick A. Pascoal(Montreal Neurological Institute and Hospital), Brian J. Lopresti(University of Pittsburgh), Helmet T. Karim(University of Pittsburgh), Layla Banihashemi(University of Pittsburgh), Meryl A. Butters, Dana Tudorascu(University of Pittsburgh)
Cited by 2
Related Papers
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
|Nature Aging|2022|300
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
|JAMA Neurology|2022|261
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
|Nature Reviews Neurology|2024|171